- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
A
ARCT
Arcturus Therape
7.08
0.02+0.28%After Hours: 7.05 -0.03 -0.42%19:38 03/26 EDT
OPEN/PREV CLOSE7.00/7.06
TODAY RANGE6.98-7.45
VOL407.88K
MARKET CAP201.24M
52 WEEK RANGE5.85-24.17
AVG VOL (3M)493.54K
% TURNOVER1.44%
TURNOVER--
P/E (TTM)-2.9474
% RANGE6.66%
EPS(TTM)-2.4021
P/E(FORWARD)-1.6797
P/B0.9401
BVPS7.53
DIVIDEND--
P/S2.452
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP186.09M
SHARES OUTSTANDING28.42M
NEXT EARNINGS05/11-05/15
FREE FLOAT26.28M
LOT SIZE1
EX-DATE11/16/2017
News
Press Releases
Financial Reports
Profile
Benzinga·6d ago
This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
Benzinga·03/19 13:26
This Xponential Fitness Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
Benzinga·03/19 13:14
This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Benzinga·03/19 13:05
This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday
Benzinga·03/18 12:00
This Evommune Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Dow Jones·03/18 10:56
Arcturus Therapeutics Price Target Announced at $22.00/Share by B. Riley Securities
TipRanks·03/18 09:05
Arcturus Therapeutics initiated with a Buy at B. Riley
Reuters·03/18 07:36
U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks
Seeking Alpha·03/06 21:04
Arcturus Therapeutics: Downgrading To "Hold" As CF Program Shifts Population Focus
Benzinga·03/05 22:01
Demystifying Arcturus Therapeutics: Insights From 4 Analyst Reviews
Dow Jones·03/05 20:34
Arcturus Therapeutics Price Target Cut to $21.00/Share From $66.00 by Citigroup
Dow Jones·03/05 20:34
Arcturus Therapeutics Is Maintained at Buy by Citigroup
Same Industry
Name/Symbol
Change%
Price